Lantern Pharma reported cash from operations of -$2.94M and free cash flow of -$2.94M for the quarter ended Jun 2026, up 25.3% year over year. This cash flow statement covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||
| Net Income | -4.07M | -3.73M | -4.28M | -4.46M | -2.26M | -3.73M | -4.15M | -5.07M | -3.28M | -4.61M | -5.53M | -5.22M | -4.99M | -5.74M | -4.62M | -4.54M | -4.25M | -4.13M | -3.36M | -3.48M | ||||||||
| Share-based Compensation | 0.22M | 0.25M | 0.89M | 0.29M | 1.00M | 0.33M | 0.33M | 0.39M | 0.19M | 0.87M | 1.08M | 1.06M | 1.27M | 0.29M | 0.15M | 0.16M | 0.14M | 0.20M | 0.26M | 1.48M | ||||||||
| Gains from Investment Securities | 0.14M | 0.07M | 0.05M | 2.13M | ||||||||||||||||||||||||
| Asset Writedowns and Impairment | 0.03M | |||||||||||||||||||||||||||
| Cash from Operations | -4.68M | -2.04M | -3.33M | -2.73M | -4.04M | -2.67M | -3.76M | -3.59M | -3.61M | -3.39M | -3.07M | -5.19M | -5.58M | -3.97M | -4.38M | -3.94M | -4.57M | -2.79M | -3.77M | -2.94M | ||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||
| Amortizatization of Intangibles | 0.02M | -0.01M | ||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | ||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||
| Change in Account Payables | ||||||||||||||||||||||||||||
| Change in Accured Expenses | -0.54M | 1.49M | 0.74M | 2.28M | -2.14M | -0.31M | -0.07M | 0.18M | -0.77M | 0.42M | 1.27M | 0.66M | -1.03M | 0.74M | -0.02M | 0.63M | -0.81M | 0.47M | -0.71M | 0.46M | ||||||||
| Other Working Capital Changes | 0.44M | 1.12M | 0.20M | -0.73M | 0.12M | -0.53M | -0.03M | -0.50M | -0.90M | 0.82M | -0.07M | -0.62M | -0.13M | 0.03M | -0.05M | -0.40M | 0.05M | 0.36M | ||||||||||
| Investing Activities | ||||||||||||||||||||||||||||
| Capital Expenditures | 0.00M | 1.00 | 0.01M | 0.01M | 0.01M | 0.00M | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 555.00 | 1.00 | ||||||||||||||
| Change in Acquisitions & Divestments | 0.18M | 1.49M | 1.25M | 1.20M | 2.15M | 2.35M | 0.97M | 1.82M | 5.46M | 8.15M | 3.80M | 3.25M | 8.22M | 7.05M | 8.01M | 2.50M | 4.25M | 0.69M | ||||||||||
| Cash from Investing Activities | -1.00M | -0.23M | 0.18M | -0.53M | -0.07M | 0.60M | -0.96M | -0.46M | 0.23M | 0.26M | -0.56M | -0.20M | 0.68M | 3.45M | 3.24M | 3.59M | 5.93M | -1.70M | 4.25M | 0.69M | ||||||||
| Financing Activities | ||||||||||||||||||||||||||||
| Other financing activities | 0.07M | 0.30M | 0.05M | 0.01M | 887.00 | |||||||||||||||||||||||
| Debt Issuance and Repayment | ||||||||||||||||||||||||||||
| Long-Term Debt Issuances | ||||||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 0.11M | 0.03M | ||||||||||||||||||||||||||
| Net Equity Issued and Repurchased | 0.30M | 0.03M | 0.67M | |||||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||||
| Cash from Financing Activities | -0.87M | -2.18M | 0.05M | 0.01M | 0.53M | |||||||||||||||||||||||
| Exchange Rate Effect | 0.00M | -0.03M | 0.01M | 0.01M | -0.00M | -0.01M | -0.01M | -0.00M | -0.01M | 0.01M | 0.02M | -0.07M | 0.00M | 0.03M | -261.00 | 0.00M | 0.02M | -664.00 | ||||||||||
| Change in Cash | -5.69M | -3.14M | -5.33M | -3.29M | -4.10M | -2.06M | -4.72M | -4.06M | -3.39M | -3.63M | -3.58M | -5.38M | -4.87M | -0.59M | -1.13M | -0.32M | 2.33M | -3.97M | 0.49M | 1.74M | ||||||||
| Free Cash Flow | -4.69M | -2.04M | -3.33M | -2.73M | -4.04M | -2.68M | -3.77M | -3.59M | -3.62M | -3.39M | -3.07M | -5.19M | -5.59M | -3.97M | -4.38M | -3.94M | -4.57M | -2.79M | -3.77M | -2.94M | ||||||||
| Net Cash Flow | -5.69M | -3.15M | -5.33M | -3.26M | -4.11M | -2.07M | -4.72M | -4.05M | -3.38M | -3.13M | -3.57M | -5.39M | -4.89M | -0.52M | -1.14M | -0.34M | 1.36M | -3.97M | 0.48M | -2.25M |